Cloning And Mutagenesis Market Report 2026

Cloning And Mutagenesis Market Overview

• Cloning And Mutagenesis market size has reached to $3.54 billion in 2025 • Expected to grow to $8.5 billion in 2030 at a compound annual growth rate (CAGR) of 19.2% • Growth Driver: Rising Demand For Personalized Medicine To Drive Market Growth • Market Trend: Advancements In Real-Time PCR Methods Transforming The Market • North America was the largest region in 2025 and Asia-pacific is the fastest growing region.

What Is Covered Under Cloning And Mutagenesis Market?

Cloning and mutagenesis refer to interrelated techniques of molecular biology that consist of making multiple identical copies of a DNA fragment, gene, or entire genome, and mutations into a DNA sequence. Cloning and mutagenesis are used to study gene function and regulation, develop new drugs and therapeutics, and develop recombinant enzymes and proteins. The main products of cloning and mutagenesis are cloning kits, mutagenesis kits, and others. Cloning kits refer to the laboratory tools that are designed to simplify the process of cloning a specific DNA fragment or gene into a cloning vector. It is used to perform a variety of cloning experiments, such as gene cloning, subcloning, site-directed mutagenesis, and library construction. The techniques include blunt end cloning, topo PCR cloning, seamless cloning, site-directed mutagenesis, and others, that are used by academic and research institutes, biotechnology companies, others.

What Is The Cloning And Mutagenesis Market Growth Forecast?

The cloning and mutagenesis market size is expected to see rapid growth in the next few years. It will grow to $8.5 billion in 2030 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to increasing demand for gene function studies, expansion of synthetic biology applications, rising investments in therapeutic protein development, growing adoption of automated lab platforms, increasing focus on precision genome editing. Major trends in the forecast period include increasing adoption of high-fidelity cloning kits, rising use of site-directed mutagenesis techniques, growing demand for crispr-based editing tools, expansion of automated molecular biology workflows, enhanced focus on reproducibility and accuracy.

Global Cloning And Mutagenesis Market Segmentation

1) By Product: Cloning Kits, Mutagenesis Kits, Other Products 2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques 3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End Users Subsegments: 1) By Cloning Kits: Bacterial Cloning Kits, Yeast Cloning Kits, Viral Cloning Kits, Plasmid Cloning Kits 2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits, Random Mutagenesis Kits, Error-Prone PCR Kits, CRISPR Or Cas9 Mutagenesis Kits 3) By Other Products: Enzymes, Vector Systems, Accessories

What Is The Driver Of The Cloning And Mutagenesis Market?

The increasing demand for personalized medicine is expected to propel the growth of cloning and mutagenesis market going forward. Personalized medicine is an innovative healthcare approach that tailor’s medical treatment and interventions to the individual characteristics of each patient. Cloning And Mutagenesis plays crucial roles in disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing for personalized therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, marking a substantial rise from the 6 approvals recorded in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the cloning and mutagenesis industry.

Key Players In The Global Cloning And Mutagenesis Market

Major companies operating in the cloning and mutagenesis market are Thermo Fisher Scientific Inc, Takara Bio Inc, Agilent Technologies Inc, New England Biolabs Inc, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH, EZBioscience, Synbio Technologies LLC

Global Cloning And Mutagenesis Market Trends and Insights

Major companies operating in the cloning and mutagenesis markets are actively exploring advanced methods, such as PCR techniques, to gain a competitive edge in the market. Polymerase chain reaction is a laboratory technique used in molecular biology to make multiple copies of a specific DNA segment. For instance, in April 2023, Bio-Rad Laboratories, Inc., a US-based biotechnology company, launched the ID-Check Speciation Solution, a real-time PCR method for meat speciation. This solution enables the identification of animal species in food, feed, and environmental samples, offering a reliable and rapid way to verify raw material origins and enhance production line cleaning processes. It targets mitochondrial DNA from various meat species, including bovine, chicken, duck, goat, horse, sheep, swine, and turkey, with exceptional sensitivity and the ability to detect as low as 0.001% of the species DNA. The kit also features a duplex detection system for added accuracy and ease of use.

What Are Latest Mergers And Acquisitions In The Cloning And Mutagenesis Market?

In March 2023, Sartorius AG, a Germany-based multinational life science company, acquired Polyplus Transfection SA for an undisclosed amount. Through this acquisition, Sartorius aims to expand its upstream portfolio for cell and gene therapy manufacturing by integrating Polyplus’s transfection reagents, nucleic-acid delivery technologies, and GMP-grade plasmid DNA capabilities to support viral-vector production and plasmid workflows central to gene-modification research and GMP applications. Polyplus Transfection SA is a France-based company that provides services for both cloning and mutagenesis.

Regional Outlook

North America was the largest region in the cloning and mutagenesis market in 2025. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cloning And Mutagenesis Market?

The cloning and mutagenesis market includes revenues earned by entities by assay kits, biotin-peg linkers, Bira proteins, and cells. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloning and mutagenesis market also includes sales of techniques such as the isolation of DNA, cloning vectors, and DNA ligase. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.